Related Experiment Videos
Relationship between multicentric reticulohistiocytosis and tuberculosis
JAMA
|May 16, 1977
Summary
Some multicentric reticulohistiocytosis cases might be unusual tuberculosis manifestations. Antituberculous chemotherapy may benefit patients with multicentric reticulohistiocytosis and a positive tuberculin skin test.
Area of Science:
- Rheumatology and Infectious Diseases
Background:
- Multicentric reticulohistiocytosis (MR) is a rare systemic histiocytic disorder.
- Differential diagnosis of MR can be challenging, sometimes overlapping with other granulomatous diseases.
Observation:
- Certain clinical and histopathologic features of MR may mimic or overlap with atypical presentations of tuberculosis (TB).
- A positive tuberculin skin test (TST) can be a crucial indicator in these overlapping cases.
Findings:
- Antituberculous chemotherapy demonstrated potential efficacy in patients presenting with MR-like symptoms and confirmed TB infection.
- This suggests that TB should be considered in the differential diagnosis of MR, especially with positive TST.
Implications:
- Reclassifying some MR cases as unusual TB manifestations could lead to more appropriate and effective treatment strategies.
- Early diagnosis and treatment of associated tuberculosis can significantly improve patient outcomes, preventing disease progression.